{"nct_id":"NCT05259917","title":"A Phase III, Crossover Trial Evaluating the Efficacy and Safety of KVD900 (Sebetralstat) for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients With Hereditary Angioedema (HAE)","status":"COMPLETED","status_verified_date":"2025-04","start_date":"2022-02-22","start_date_type":"ACTUAL","primary_completion_date":"2023-12-31","primary_completion_date_type":"ACTUAL","completion_date":"2023-12-31","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["KALV"]}